Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 1
1984 1
1985 1
1986 1
1987 1
1988 3
1989 1
1990 5
1991 7
1992 4
1993 9
1994 8
1995 5
1996 6
1997 4
1998 3
1999 5
2000 3
2002 4
2003 4
2004 4
2005 3
2006 5
2007 1
2008 4
2009 7
2010 5
2011 8
2012 6
2013 6
2014 9
2015 9
2016 8
2017 9
2018 8
2019 16
2020 16
2021 12
2022 9
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Therapy-related myeloid neoplasms: clinical perspectives.
Fianchi L, Criscuolo M, Fabiani E, Falconi G, Maraglino AME, Voso MT, Pagano L. Fianchi L, et al. Among authors: criscuolo m. Onco Targets Ther. 2018 Sep 17;11:5909-5915. doi: 10.2147/OTT.S101333. eCollection 2018. Onco Targets Ther. 2018. PMID: 30271175 Free PMC article. Review.
Mastocytosis: One Word for Different Diseases.
Criscuolo M, Fianchi L, Maraglino AME, Pagano L. Criscuolo M, et al. Oncol Ther. 2018 Dec;6(2):129-140. doi: 10.1007/s40487-018-0086-2. Epub 2018 Oct 29. Oncol Ther. 2018. PMID: 32700030 Free PMC article. Review.
Treatment of Indolent and Advanced Systemic Mastocytosis.
Buonomo A, Nucera E, Criscuolo M. Buonomo A, et al. Among authors: criscuolo m. Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022040. doi: 10.4084/MJHID.2022.040. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35615325 Free PMC article. Review.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Salmanton-García J, Marchesi F, Koehler P, Weinbergerová B, Čolović N, Falces-Romero I, Buquicchio C, Farina F, van Praet J, Biernat MM, Itri F, Prezioso L, Tascini C, Vena A, Romano A, Delia M, Dávila-Valls J, Martín-Pérez S, Lavilla-Rubira E, Adžić-Vukičević T, García-Bordallo D, López-García A, Criscuolo M, Petzer V, Fracchiolla NS, Espigado I, Sili U, Meers S, Erben N, Cattaneo C, Tragiannidis A, Gavriilaki E, Schönlein M, Mitrovic M, Pantic N, Merelli M, Labrador J, Hernández-Rivas JÁ, Glenthøj A, Fouquet G, Del Principe MI, Dargenio M, Calbacho M, Besson C, Kohn M, Gräfe S, Hersby DS, Arellano E, Çolak GM, Wolf D, Marchetti M, Nordlander A, Blennow O, Cordoba R, Mišković B, Mladenović M, Bavastro M, Limongelli A, Rahimli L, Pagano L, Cornely OA. Salmanton-García J, et al. Among authors: criscuolo m. Int J Antimicrob Agents. 2023 Oct;62(4):106952. doi: 10.1016/j.ijantimicag.2023.106952. Epub 2023 Aug 13. Int J Antimicrob Agents. 2023. PMID: 37582478 Free article.
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Trecarichi EM, Giuliano G, Cattaneo C, Ballanti S, Criscuolo M, Candoni A, Marchesi F, Laurino M, Dargenio M, Fanci R, Cefalo M, Delia M, Spolzino A, Maracci L, Bonuomo V, Busca A, Principe MID, Daffini R, Simonetti E, Dragonetti G, Zannier ME, Pagano L, Tumbarello M; Hematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry – Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne (SEIFEM) group, Italy. Trecarichi EM, et al. Among authors: criscuolo m. Int J Antimicrob Agents. 2023 Jun;61(6):106806. doi: 10.1016/j.ijantimicag.2023.106806. Epub 2023 Apr 6. Int J Antimicrob Agents. 2023. PMID: 37030470 Free article.
Treatment of Low-Blast Count AML using Hypomethylating Agents.
De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT. De Bellis E, et al. Among authors: criscuolo m. Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 28698788 Free PMC article. Review.
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence.
Signoriello E, Lus G, Saccà F, Puthenparampil M, Coppola C, Di Pietro A, Puoti G, Criscuolo MC, Foschi M, Miele G, Abbadessa G, Brescia Morra V, Gallo P, Bonavita S, Sormani MP, Signori A. Signoriello E, et al. Among authors: criscuolo mc. J Clin Med. 2023 Feb 22;12(5):1768. doi: 10.3390/jcm12051768. J Clin Med. 2023. PMID: 36902555 Free PMC article.
207 results